Exact Mass: 616.4491

Exact Mass Matches: 616.4491

Found 500 metabolites which its exact mass value is equals to given mass value 616.4491, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Tsugarioside B

[4,4,10,13,14-pentamethyl-17-[6-methyl-1-(3,4,5-trihydroxyoxan-2-yl)oxyhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

C37H60O7 (616.4339)


Tsugarioside B is found in mushrooms. Tsugarioside B is a constituent of Ganoderma tsugae (red reishi) Constituent of Ganoderma tsugae (red reishi). Tsugarioside B is found in mushrooms.

   

Oryzanol C

7,7,12,16-Tetramethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid

C41H60O4 (616.4491)


Oryzanol C is from rice bran oi From rice bran oil

   

DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,7R,8E,10Z,13Z,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0)

(2S)-3-(dodecanoyloxy)-2-hydroxypropyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

(2S)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl (4Z,7Z,10R,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

(2R)-3-(dodecanoyloxy)-2-hydroxypropyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0)

(2S)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,7R,8E,10Z,13Z,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

(2R)-2-hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (4Z,7Z,10R,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0)

(2S)-3-hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0)

(2S)-3-hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0)

(2S)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Oryzanol B

[(1S,3R,6S,8R,11S,15R,16R)-7,7,11,16-Tetramethyl-15-[(2R)-6-methyl-5-methylideneheptan-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C41H60O4 (616.4491)


Oryzanol b is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Oryzanol b can be found in rice, which makes oryzanol b a potential biomarker for the consumption of this food product.

   

hedyotisol A

(16R)-7,7,12,16-tetramethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecan-6-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C41H60O4 (616.4491)


   

Bacchalatiofolin

Bacchalatiofolin

C38H64O6 (616.4703)


   

argentinic acid A methyl ester

argentinic acid A methyl ester

C37H60O7 (616.4339)


   

C(19)-Obtusilacton dimer

C(19)-Obtusilacton dimer

C38H64O6 (616.4703)


   

Inundoside B

Inundoside B

C37H60O7 (616.4339)


   

cholest-14-ene-3,7,24,25-tetrol-21,23-epoxy-21-methoxy-4,4,8-trimethyl-3-(3-methyl-2-butenoate)

cholest-14-ene-3,7,24,25-tetrol-21,23-epoxy-21-methoxy-4,4,8-trimethyl-3-(3-methyl-2-butenoate)

C37H60O7 (616.4339)


   

cyclomargenyl-3-O-beta-caffeoyl ester

cyclomargenyl-3-O-beta-caffeoyl ester

C41H60O4 (616.4491)


   

cyclobranyl ferulate

cyclobranyl ferulate

C41H60O4 (616.4491)


   

Oryzanol C

[(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methyl-5-methylideneheptan-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C41H60O4 (616.4491)


Oryzanol C is a triterpenoid. 24-Methylenecycloartanyl ferulate is a γ-oryzanol compound. 24-Methylenecycloartanyl ferulate promotes parvin-beta expression in human breast cancer cells. 24-Methylenecycloartanyl ferulate is a potential ATP-competitive Akt1 inhibitor (EC50= 33.3μM)[1]. 24-Methylenecycloartanyl ferulate is a γ-oryzanol compound. 24-Methylenecycloartanyl ferulate promotes parvin-beta expression in human breast cancer cells. 24-Methylenecycloartanyl ferulate is a potential ATP-competitive Akt1 inhibitor (EC50= 33.3μM)[1]. 24-Methylenecycloartanyl ferulate is a γ-oryzanol compound. 24-Methylenecycloartanyl ferulate promotes parvin-beta expression in human breast cancer cells. 24-Methylenecycloartanyl ferulate is a potential ATP-competitive Akt1 inhibitor (EC50= 33.3μM)[1].

   

PA(P-16:0/15:1(9Z))

1-(1Z-hexadecenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C34H65O7P (616.4468)


   

Tsugarioside B

2,6,6,11,15-pentamethyl-14-{6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl}tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-5-yl acetate

C37H60O7 (616.4339)


   

PA O-31:2

1-(1Z-hexadecenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C34H65O7P (616.4468)


   

DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C37H60O7 (616.4339)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0)

C37H60O7 (616.4339)


   

DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C37H60O7 (616.4339)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0)

C37H60O7 (616.4339)


   

DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H60O7 (616.4339)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0)

C37H60O7 (616.4339)


   

DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C37H60O7 (616.4339)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0)

C37H60O7 (616.4339)


   

DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C37H60O7 (616.4339)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0)

C37H60O7 (616.4339)


   

DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C37H60O7 (616.4339)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0)

C37H60O7 (616.4339)


   

DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H60O7 (616.4339)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0)

C37H60O7 (616.4339)


   

DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C37H60O7 (616.4339)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0)

C37H60O7 (616.4339)


   

[(16R)-7,7,12,16-tetramethyl-15-(6-methyl-5-methylideneheptan-2-yl)-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[(16R)-7,7,12,16-tetramethyl-15-(6-methyl-5-methylideneheptan-2-yl)-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C41H60O4 (616.4491)


   

N-[(3R,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3R,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3R,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3R,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3R,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3R,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3R,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3R,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3R,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3R,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

N-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

N-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C35H60N4O5 (616.4563)


   

Mgdg O-16:1_9:0

Mgdg O-16:1_9:0

C34H64O9 (616.455)


   

Mgdg O-20:1_5:0

Mgdg O-20:1_5:0

C34H64O9 (616.455)


   

Mgdg O-8:0_17:1

Mgdg O-8:0_17:1

C34H64O9 (616.455)


   

Mgdg O-17:1_8:0

Mgdg O-17:1_8:0

C34H64O9 (616.455)


   

Mgdg O-9:0_16:1

Mgdg O-9:0_16:1

C34H64O9 (616.455)


   

Mgdg O-21:1_4:0

Mgdg O-21:1_4:0

C34H64O9 (616.455)


   

Mgdg O-19:1_6:0

Mgdg O-19:1_6:0

C34H64O9 (616.455)


   

Mgdg O-22:1_3:0

Mgdg O-22:1_3:0

C34H64O9 (616.455)


   

Mgdg O-18:1_7:0

Mgdg O-18:1_7:0

C34H64O9 (616.455)


   

Mgdg O-13:1_12:0

Mgdg O-13:1_12:0

C34H64O9 (616.455)


   

Mgdg O-14:1_11:0

Mgdg O-14:1_11:0

C34H64O9 (616.455)


   

Mgdg O-12:0_13:1

Mgdg O-12:0_13:1

C34H64O9 (616.455)


   

Mgdg O-15:1_10:0

Mgdg O-15:1_10:0

C34H64O9 (616.455)


   

Mgdg O-11:0_14:1

Mgdg O-11:0_14:1

C34H64O9 (616.455)


   

Mgdg O-10:0_15:1

Mgdg O-10:0_15:1

C34H64O9 (616.455)


   

PE-Cer 12:1;2O/19:1

PE-Cer 12:1;2O/19:1

C33H65N2O6P (616.458)


   

PE-Cer 15:2;2O/16:0

PE-Cer 15:2;2O/16:0

C33H65N2O6P (616.458)


   

PE-Cer 19:2;2O/12:0

PE-Cer 19:2;2O/12:0

C33H65N2O6P (616.458)


   

PE-Cer 15:0;2O/16:2

PE-Cer 15:0;2O/16:2

C33H65N2O6P (616.458)


   

PE-Cer 16:1;2O/15:1

PE-Cer 16:1;2O/15:1

C33H65N2O6P (616.458)


   

PE-Cer 17:1;2O/14:1

PE-Cer 17:1;2O/14:1

C33H65N2O6P (616.458)


   

PE-Cer 12:2;2O/19:0

PE-Cer 12:2;2O/19:0

C33H65N2O6P (616.458)


   

PE-Cer 13:0;2O/18:2

PE-Cer 13:0;2O/18:2

C33H65N2O6P (616.458)


   

PE-Cer 14:1;2O/17:1

PE-Cer 14:1;2O/17:1

C33H65N2O6P (616.458)


   

PE-Cer 13:1;2O/18:1

PE-Cer 13:1;2O/18:1

C33H65N2O6P (616.458)


   

PE-Cer 15:1;2O/16:1

PE-Cer 15:1;2O/16:1

C33H65N2O6P (616.458)


   

PE-Cer 12:0;2O/19:2

PE-Cer 12:0;2O/19:2

C33H65N2O6P (616.458)


   

PE-Cer 14:0;2O/17:2

PE-Cer 14:0;2O/17:2

C33H65N2O6P (616.458)


   

PE-Cer 14:2;2O/17:0

PE-Cer 14:2;2O/17:0

C33H65N2O6P (616.458)


   

PE-Cer 18:2;2O/13:0

PE-Cer 18:2;2O/13:0

C33H65N2O6P (616.458)


   

PE-Cer 17:2;2O/14:0

PE-Cer 17:2;2O/14:0

C33H65N2O6P (616.458)


   

PE-Cer 16:2;2O/15:0

PE-Cer 16:2;2O/15:0

C33H65N2O6P (616.458)


   

PE-Cer 13:2;2O/18:0

PE-Cer 13:2;2O/18:0

C33H65N2O6P (616.458)


   

PE-Cer 18:1;2O/13:1

PE-Cer 18:1;2O/13:1

C33H65N2O6P (616.458)


   

PE-Cer 18:3;2O/12:0;O

PE-Cer 18:3;2O/12:0;O

C32H61N2O7P (616.4216)


   

PE-Cer 14:3;2O/16:0;O

PE-Cer 14:3;2O/16:0;O

C32H61N2O7P (616.4216)


   

PE-Cer 12:2;2O/18:1;O

PE-Cer 12:2;2O/18:1;O

C32H61N2O7P (616.4216)


   

PE-Cer 18:2;2O/12:1;O

PE-Cer 18:2;2O/12:1;O

C32H61N2O7P (616.4216)


   

PE-Cer 15:2;2O/15:1;O

PE-Cer 15:2;2O/15:1;O

C32H61N2O7P (616.4216)


   

PE-Cer 17:3;2O/13:0;O

PE-Cer 17:3;2O/13:0;O

C32H61N2O7P (616.4216)


   

PE-Cer 12:1;2O/18:2;O

PE-Cer 12:1;2O/18:2;O

C32H61N2O7P (616.4216)


   

PE-Cer 15:3;2O/15:0;O

PE-Cer 15:3;2O/15:0;O

C32H61N2O7P (616.4216)


   

[(4E,8E)-2-acetamido-3-hydroxyhexacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-acetamido-3-hydroxyhexacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-3-hydroxy-2-(nonanoylamino)nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(nonanoylamino)nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-2-(butanoylamino)-3-hydroxytetracosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(butanoylamino)-3-hydroxytetracosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-3-hydroxy-2-(propanoylamino)pentacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(propanoylamino)pentacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-3-hydroxy-2-(octanoylamino)icosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(octanoylamino)icosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-3-hydroxy-2-(pentanoylamino)tricosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(pentanoylamino)tricosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-2-(hexanoylamino)-3-hydroxydocosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(hexanoylamino)-3-hydroxydocosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-2-(heptanoylamino)-3-hydroxyhenicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(heptanoylamino)-3-hydroxyhenicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-2-(decanoylamino)-3-hydroxyoctadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(decanoylamino)-3-hydroxyoctadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-3-hydroxy-2-(undecanoylamino)heptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(undecanoylamino)heptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-2-(hexadecanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(hexadecanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

(2-nonanoyloxy-3-octanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

(2-nonanoyloxy-3-octanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C38H64O6 (616.4703)


   

(2-decanoyloxy-3-nonanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(2-decanoyloxy-3-nonanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C38H64O6 (616.4703)


   

(3-octanoyloxy-2-undecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(3-octanoyloxy-2-undecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C38H64O6 (616.4703)


   

[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(4E,8E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(2S,3R,4E,6E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,6E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(2S,3R,4E,8E)-2-(decanoylamino)-3-hydroxyoctadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,8E)-2-(decanoylamino)-3-hydroxyoctadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(2S,3R,4E,8E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,8E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(2S,3R,4E,8E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,8E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(2S,3R,4E,6E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,6E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(2S,3R,4E,6E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,6E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

[(2S,3R,4E,14E)-2-(decanoylamino)-3-hydroxyoctadeca-4,14-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,14E)-2-(decanoylamino)-3-hydroxyoctadeca-4,14-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H65N2O6P (616.458)


   

2-[hydroxy-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

2-[[2-heptanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-heptanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

2-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

TG(35:4)

TG(6:0_11:3_18:1)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

FAHFA 15:3/O-26:7

FAHFA 15:3/O-26:7

C41H60O4 (616.4491)


   

FAHFA 15:4/O-26:6

FAHFA 15:4/O-26:6

C41H60O4 (616.4491)


   

FAHFA 15:5/O-26:5

FAHFA 15:5/O-26:5

C41H60O4 (616.4491)


   

FAHFA 16:3/O-25:7

FAHFA 16:3/O-25:7

C41H60O4 (616.4491)


   

FAHFA 16:4/O-25:6

FAHFA 16:4/O-25:6

C41H60O4 (616.4491)


   

FAHFA 16:5/O-25:5

FAHFA 16:5/O-25:5

C41H60O4 (616.4491)


   

FAHFA 17:3/O-24:7

FAHFA 17:3/O-24:7

C41H60O4 (616.4491)


   

FAHFA 17:4/O-24:6

FAHFA 17:4/O-24:6

C41H60O4 (616.4491)


   

FAHFA 17:5/O-24:5

FAHFA 17:5/O-24:5

C41H60O4 (616.4491)


   

FAHFA 18:3/O-23:7

FAHFA 18:3/O-23:7

C41H60O4 (616.4491)


   

FAHFA 18:4/O-23:6

FAHFA 18:4/O-23:6

C41H60O4 (616.4491)


   

FAHFA 18:5/O-23:5

FAHFA 18:5/O-23:5

C41H60O4 (616.4491)


   

FAHFA 18:6/O-23:4

FAHFA 18:6/O-23:4

C41H60O4 (616.4491)


   

FAHFA 19:3/O-22:7

FAHFA 19:3/O-22:7

C41H60O4 (616.4491)


   

FAHFA 19:4/O-22:6

FAHFA 19:4/O-22:6

C41H60O4 (616.4491)


   

FAHFA 19:5/O-22:5

FAHFA 19:5/O-22:5

C41H60O4 (616.4491)


   

FAHFA 19:6/O-22:4

FAHFA 19:6/O-22:4

C41H60O4 (616.4491)


   

FAHFA 20:3/O-21:7

FAHFA 20:3/O-21:7

C41H60O4 (616.4491)


   

FAHFA 20:4/O-21:6

FAHFA 20:4/O-21:6

C41H60O4 (616.4491)


   

FAHFA 20:5/O-21:5

FAHFA 20:5/O-21:5

C41H60O4 (616.4491)


   

FAHFA 20:6/O-21:4

FAHFA 20:6/O-21:4

C41H60O4 (616.4491)


   

FAHFA 21:4/O-20:6

FAHFA 21:4/O-20:6

C41H60O4 (616.4491)


   

FAHFA 21:5/O-20:5

FAHFA 21:5/O-20:5

C41H60O4 (616.4491)


   

FAHFA 21:6/O-20:4

FAHFA 21:6/O-20:4

C41H60O4 (616.4491)


   

FAHFA 21:7/O-20:3

FAHFA 21:7/O-20:3

C41H60O4 (616.4491)


   

FAHFA 22:4/O-19:6

FAHFA 22:4/O-19:6

C41H60O4 (616.4491)


   

FAHFA 22:5/O-19:5

FAHFA 22:5/O-19:5

C41H60O4 (616.4491)


   

FAHFA 22:6/O-19:4

FAHFA 22:6/O-19:4

C41H60O4 (616.4491)


   

FAHFA 22:7/O-19:3

FAHFA 22:7/O-19:3

C41H60O4 (616.4491)


   

FAHFA 23:4/O-18:6

FAHFA 23:4/O-18:6

C41H60O4 (616.4491)


   

FAHFA 23:5/O-18:5

FAHFA 23:5/O-18:5

C41H60O4 (616.4491)


   

FAHFA 23:6/O-18:4

FAHFA 23:6/O-18:4

C41H60O4 (616.4491)


   

FAHFA 23:7/O-18:3

FAHFA 23:7/O-18:3

C41H60O4 (616.4491)


   

FAHFA 24:5/O-17:5

FAHFA 24:5/O-17:5

C41H60O4 (616.4491)


   

FAHFA 24:6/O-17:4

FAHFA 24:6/O-17:4

C41H60O4 (616.4491)


   

FAHFA 24:7/O-17:3

FAHFA 24:7/O-17:3

C41H60O4 (616.4491)


   

FAHFA 25:5/O-16:5

FAHFA 25:5/O-16:5

C41H60O4 (616.4491)


   

FAHFA 25:6/O-16:4

FAHFA 25:6/O-16:4

C41H60O4 (616.4491)


   

FAHFA 25:7/O-16:3

FAHFA 25:7/O-16:3

C41H60O4 (616.4491)


   

FAHFA 26:5/O-15:5

FAHFA 26:5/O-15:5

C41H60O4 (616.4491)


   

FAHFA 26:6/O-15:4

FAHFA 26:6/O-15:4

C41H60O4 (616.4491)


   

FAHFA 26:7/O-15:3

FAHFA 26:7/O-15:3

C41H60O4 (616.4491)


   

FAHFA 41:10;O

FAHFA 41:10;O

C41H60O4 (616.4491)


   

MGDG O-25:1

MGDG O-25:1

C34H64O9 (616.455)


   

MGMG 25:1

MGMG 25:1

C34H64O9 (616.455)


   

PA O-14:0/17:2

PA O-14:0/17:2

C34H65O7P (616.4468)


   

PA O-14:1/17:1

PA O-14:1/17:1

C34H65O7P (616.4468)


   

PA O-16:1/15:1

PA O-16:1/15:1

C34H65O7P (616.4468)


   

PA O-16:2/15:0

PA O-16:2/15:0

C34H65O7P (616.4468)


   

PA O-18:2/13:0

PA O-18:2/13:0

C34H65O7P (616.4468)


   

PA O-20:2/11:0

PA O-20:2/11:0

C34H65O7P (616.4468)


   

PA P-14:0/17:1

PA P-14:0/17:1

C34H65O7P (616.4468)


   

PA P-14:0/17:1 or PA O-14:1/17:1

PA P-14:0/17:1 or PA O-14:1/17:1

C34H65O7P (616.4468)


   

PA P-16:0/15:1

PA P-16:0/15:1

C34H65O7P (616.4468)


   

PA P-16:0/15:1 or PA O-16:1/15:1

PA P-16:0/15:1 or PA O-16:1/15:1

C34H65O7P (616.4468)


   

PA P-16:1/15:0

PA P-16:1/15:0

C34H65O7P (616.4468)


   

PA P-16:1/15:0 or PA O-16:2/15:0

PA P-16:1/15:0 or PA O-16:2/15:0

C34H65O7P (616.4468)


   

PA P-18:1/13:0

PA P-18:1/13:0

C34H65O7P (616.4468)


   

PA P-18:1/13:0 or PA O-18:2/13:0

PA P-18:1/13:0 or PA O-18:2/13:0

C34H65O7P (616.4468)


   

PA P-20:1/11:0

PA P-20:1/11:0

C34H65O7P (616.4468)


   

PA P-20:1/11:0 or PA O-20:2/11:0

PA P-20:1/11:0 or PA O-20:2/11:0

C34H65O7P (616.4468)


   
   

PA P-31:1 or PA O-31:2

PA P-31:1 or PA O-31:2

C34H65O7P (616.4468)


   
   
   

CerPE 14:0;O2/17:2

CerPE 14:0;O2/17:2

C33H65N2O6P (616.458)


   

CerPE 14:1;O2/17:1

CerPE 14:1;O2/17:1

C33H65N2O6P (616.458)


   

CerPE 14:2;O2/17:0

CerPE 14:2;O2/17:0

C33H65N2O6P (616.458)


   

CerPE 15:1;O2/16:1

CerPE 15:1;O2/16:1

C33H65N2O6P (616.458)


   

CerPE 15:2;O2/16:0

CerPE 15:2;O2/16:0

C33H65N2O6P (616.458)


   

CerPE 16:1;O2/15:1

CerPE 16:1;O2/15:1

C33H65N2O6P (616.458)


   

CerPE 16:2;O2/15:0

CerPE 16:2;O2/15:0

C33H65N2O6P (616.458)


   

CerPE 17:1;O2/14:1

CerPE 17:1;O2/14:1

C33H65N2O6P (616.458)


   

CerPE 17:2;O2/14:0

CerPE 17:2;O2/14:0

C33H65N2O6P (616.458)


   

CerPE 18:2;O2/13:0

CerPE 18:2;O2/13:0

C33H65N2O6P (616.458)


   

CerPE 19:2;O2/12:0

CerPE 19:2;O2/12:0

C33H65N2O6P (616.458)


   

CerPE 20:2;O2/11:0

CerPE 20:2;O2/11:0

C33H65N2O6P (616.458)


   

CerPE 21:2;O2/10:0

CerPE 21:2;O2/10:0

C33H65N2O6P (616.458)


   
   

SM 14:1;O2/14:1

SM 14:1;O2/14:1

C33H65N2O6P (616.458)


   

SM 14:2;O2/14:0

SM 14:2;O2/14:0

C33H65N2O6P (616.458)


   

SM 15:2;O2/13:0

SM 15:2;O2/13:0

C33H65N2O6P (616.458)


   

SM 16:2;O2/12:0

SM 16:2;O2/12:0

C33H65N2O6P (616.458)


   

SM 17:2;O2/11:0

SM 17:2;O2/11:0

C33H65N2O6P (616.458)


   

SM 18:2;O2/10:0

SM 18:2;O2/10:0

C33H65N2O6P (616.458)


   
   
   
   

(3s,3as,5ar,6r,7r,9r,9ar)-7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl (2r,3r)-2-hydroxy-3-methylpentanoate

(3s,3as,5ar,6r,7r,9r,9ar)-7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl (2r,3r)-2-hydroxy-3-methylpentanoate

C37H60O7 (616.4339)


   

3-hydroxy-15-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

3-hydroxy-15-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)


   

3a,6,6,9a,11a-pentamethyl-1-{6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

3a,6,6,9a,11a-pentamethyl-1-{6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)


   

[(2r)-5-oxo-1,4-dioxacyclooctacosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[(2r)-5-oxo-1,4-dioxacyclooctacosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C37H60O7 (616.4339)


   

7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl 2-hydroxy-3-methylpentanoate

7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl 2-hydroxy-3-methylpentanoate

C37H60O7 (616.4339)


   

(2r,4ar,8r,8as)-8-[(3s)-5-hydroxy-3-methylpentyl]-4,4,7,8a-tetramethyl-1,2,3,4a,5,8-hexahydronaphthalen-2-yl 1-[(1s,4r)-4-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]cyclohexyl]methyl propanedioate

(2r,4ar,8r,8as)-8-[(3s)-5-hydroxy-3-methylpentyl]-4,4,7,8a-tetramethyl-1,2,3,4a,5,8-hexahydronaphthalen-2-yl 1-[(1s,4r)-4-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]cyclohexyl]methyl propanedioate

C38H64O6 (616.4703)


   

(1r,3ar,5as,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2s,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3ar,5as,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2s,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)


   

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)


   

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2r,3s,5r)-5-[(1r)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2r,3s,5r)-5-[(1r)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)


   

(5-oxo-1,4-dioxacyclooctacosan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(5-oxo-1,4-dioxacyclooctacosan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C37H60O7 (616.4339)


   

1,7,7,11,16,20,20-heptamethyl-19-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

1,7,7,11,16,20,20-heptamethyl-19-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C37H60O7 (616.4339)


   

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)


   

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)


   

(1r,3s,3ar,5ar,7r,9as,11ar)-3-hydroxy-1-[(2r)-1-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl 1-methyl (3s)-3-hydroxy-3-methylpentanedioate

(1r,3s,3ar,5ar,7r,9as,11ar)-3-hydroxy-1-[(2r)-1-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl 1-methyl (3s)-3-hydroxy-3-methylpentanedioate

C37H60O7 (616.4339)


   

(1s,6r,8s,11r,12s,15s,16r,19s,21r)-1,7,7,11,16,20,20-heptamethyl-19-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

(1s,6r,8s,11r,12s,15s,16r,19s,21r)-1,7,7,11,16,20,20-heptamethyl-19-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C37H60O7 (616.4339)


   

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-3-hydroxy-15-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-3-hydroxy-15-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)


   

TG(3:0_14:2_18:2)

TG(3:0_14:2_18:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(17:3_18:1)

TG(17:3_18:1)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(17:2_18:2)

TG(17:2_18:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(31:4CHO_3:0)

TG(31:4(1CHO)_3:0)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(34:4CHO)

TG(34:4(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(6:0_11:2_18:2)

TG(6:0_11:2_18:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(17:1_18:3)

TG(17:1_18:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

CerPE(d31:2)

CerPE(d31:2)

C33H65N2O6P (616.458)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(18:1_6:0_10:3CHO)

TG(18:1_6:0_10:3(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(19:1_6:0_10:3)

TG(19:1_6:0_10:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(21:4_6:0_8:0)

TG(21:4_6:0_8:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(18:2_6:0_11:2)

TG(18:2_6:0_11:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(20:2_4:0_11:2)

TG(20:2_4:0_11:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(3:0_13:2CHO_18:2)

TG(3:0_13:2(1CHO)_18:2)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(23:4_6:0_6:0)

TG(23:4_6:0_6:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

DAP(O-33:6)

DAP(O-33:6)

C41H60O4 (616.4491)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

DG(P-38:10)

DG(P-38:10)

C41H60O4 (616.4491)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(20:1_14:3CHO)

TG(20:1_14:3(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

AcHexZyE(4:0)

AcHexZyE(4:0)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(19:1_15:3CHO)

TG(19:1_15:3(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

SM(d18:1_10:1)

SM(d18:1_10:1)

C33H65N2O6P (616.458)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(14:2_3:0_17:2CHO)

TG(14:2_3:0_17:2(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

SM(d28:2)

SM(d28:2)

C33H65N2O6P (616.458)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

BisMeLPA(29:2)

BisMeLPA(29:2)

C34H65O7P (616.4468)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(32:4_3:0)

TG(32:4_3:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(11:0CHO_23:4)

TG(11:0(1CHO)_23:4)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(21:2_3:0_10:2CHO)

TG(21:2_3:0_10:2(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(29:4_3:0_3:0)

TG(29:4_3:0_3:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(30:4_4:0CHO)

TG(30:4_4:0(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(14:2_3:0_18:2)

TG(14:2_3:0_18:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(23:3_3:0_8:1CHO)

TG(23:3_3:0_8:1(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PEt(O-17:1_12:1)

PEt(O-17:1_12:1)

C34H65O7P (616.4468)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(17:3_17:1CHO)

TG(17:3_17:1(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(10:1_11:1_14:2)

TG(10:1_11:1_14:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(15:2_9:0_11:2)

TG(15:2_9:0_11:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(22:4_13:0)

TG(22:4_13:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(11:0_6:0_17:4CHO)

TG(11:0_6:0_17:4(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(16:0_18:4CHO)

TG(16:0_18:4(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(2:0_15:1_18:3)

TG(2:0_15:1_18:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(4:0_11:0_20:4)

TG(4:0_11:0_20:4)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(17:2_17:2CHO)

TG(17:2_17:2(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(12:1_5:0_18:3)

TG(12:1_5:0_18:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(6:0_11:2_17:2CHO)

TG(6:0_11:2_17:2(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(11:2_6:0_17:2CHO)

TG(11:2_6:0_17:2(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(22:4CHO_6:0_6:0)

TG(22:4(1CHO)_6:0_6:0)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(16:3CHO_18:1)

TG(16:3(1CHO)_18:1)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(20:4CHO_6:0_8:0)

TG(20:4(1CHO)_6:0_8:0)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(12:0_23:4)

TG(12:0_23:4)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(7:0_8:0_20:4)

TG(7:0_8:0_20:4)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(13:0_3:0_18:4CHO)

TG(13:0_3:0_18:4(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(14:3_20:1CHO)

TG(14:3_20:1(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(6:0_6:0_23:4)

TG(6:0_6:0_23:4)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(18:4CHO_8:0_8:0)

TG(18:4(1CHO)_8:0_8:0)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(6:0_9:0_20:4)

TG(6:0_9:0_20:4)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

CerPE(d18:1_13:1)

CerPE(d18:1_13:1)

C33H65N2O6P (616.458)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PEt(O-29:2)

PEt(O-29:2)

C34H65O7P (616.4468)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(19:4CHO_15:0)

TG(19:4(1CHO)_15:0)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(27:4_2:0_5:0CHO)

TG(27:4_2:0_5:0(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(25:4CHO_9:0)

TG(25:4(1CHO)_9:0)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(19:3_6:0_10:1)

TG(19:3_6:0_10:1)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(19:2_6:0_10:2)

TG(19:2_6:0_10:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(17:1_8:0_10:3)

TG(17:1_8:0_10:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(5:0_15:2_15:2)

TG(5:0_15:2_15:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(16:2CHO_18:2)

TG(16:2(1CHO)_18:2)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(18:4_5:0_12:0)

TG(18:4_5:0_12:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(10:3_7:0_18:1)

TG(10:3_7:0_18:1)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(21:2_5:0_7:2CHO)

TG(21:2_5:0_7:2(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PEt(O-14:2_15:0)

PEt(O-14:2_15:0)

C34H65O7P (616.4468)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(26:2_7:2CHO)

TG(26:2_7:2(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(2:0_15:2_18:2)

TG(2:0_15:2_18:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(19:4_8:0_8:0)

TG(19:4_8:0_8:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(3:0_14:0_17:4CHO)

TG(3:0_14:0_17:4(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

CerPE(d17:2_14:0)

CerPE(d17:2_14:0)

C33H65N2O6P (616.458)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(17:3_4:0_13:1CHO)

TG(17:3_4:0_13:1(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(4:0_12:0_19:4)

TG(4:0_12:0_19:4)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(19:3_6:0_9:1CHO)

TG(19:3_6:0_9:1(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(25:4_4:0_6:0)

TG(25:4_4:0_6:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(25:4_10:0)

TG(25:4_10:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(30:4CHO_4:0)

TG(30:4(1CHO)_4:0)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(20:4CHO_4:0_10:0)

TG(20:4(1CHO)_4:0_10:0)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(21:4_14:0)

TG(21:4_14:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(17:3_8:0_9:1CHO)

TG(17:3_8:0_9:1(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(11:2_6:0_18:2)

TG(11:2_6:0_18:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(3:0_16:1_16:3)

TG(3:0_16:1_16:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(7:0_18:1_10:3)

TG(7:0_18:1_10:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(13:1_6:0_16:3)

TG(13:1_6:0_16:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(5:0_12:1_18:3)

TG(5:0_12:1_18:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(10:2_14:0_11:2)

TG(10:2_14:0_11:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(14:0_10:2_11:2)

TG(14:0_10:2_11:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(3:0_12:1_19:3CHO)

TG(3:0_12:1_19:3(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(14:1_11:1_9:2CHO)

TG(14:1_11:1_9:2(1CHO))

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(19:3CHO_15:1)

TG(19:3(1CHO)_15:1)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(7:0_10:2_18:2)

TG(7:0_10:2_18:2)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PEt(O-11:0_18:2)

PEt(O-11:0_18:2)

C34H65O7P (616.4468)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(18:1_17:3)

TG(18:1_17:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(5:0CHO_14:2_15:2)

TG(5:0(1CHO)_14:2_15:2)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

DG(P-20:6_18:4)

DG(P-20:6_18:4)

C41H60O4 (616.4491)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(4:0CHO_15:2_15:2)

TG(4:0(1CHO)_15:2_15:2)

C37H60O7 (616.4339)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(8:0_17:1_10:3)

TG(8:0_17:1_10:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(25:4_2:0_8:0)

TG(25:4_2:0_8:0)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(17:1_2:0_16:3)

TG(17:1_2:0_16:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(19:1_16:3)

TG(19:1_16:3)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved